MarketReportsOnline.com adds "Global Acne Treatment Market: Trends and Opportunities (2014-2019)" report to its research store.
The report titled “Global Acne Treatment Market: Trends and Opportunities (2014-2019)” provides an insight into the acne market with focus on global prescription drugs. The report assesses the market sizing and growth of the global acne market, the growth of acne market in various regions and the growth and composition of oral and topical acne drugs. The report further analyzes the major prescription drugs for the treatment of acne. The report also discusses key factors driving growth of the industry, major trends and challenges faced by manufacturers of acne drugs. Further, key players like Foamix Pharmaceuticals, Valeant Pharmaceuticals, Dermira and Actavis Plc are analyzed in the report.
Complete report available at http://www.marketreportsonline.com/396023.html.
The global acne market represents a small fraction of total dermatology market and both over the counter drugs and prescription drugs are used to treat acne. The acne market is primarily genericised and is moderately served by the currently marketed major prescribed drugs including SOLODYN, DORYX, and EPIDUO. The US market is the largest market for the global acne products with about 50 million suffering from acne in the country.
Globally, acne market is of very small size but holds immense potential driven mostly by growing income of individuals, rising health expenditures, increased fast food consumption and increased spending on drugs from various emerging economies. The acne market is also characterized by immense research and development opportunities. New laser treatment for acne, technology driven products are the key trends of the acne industry. However, with immense growth opportunities, the global acne market faces the challenges in terms of high prices of drugs, regulatory issues, increased competition from new drugs and lastly the adverse effects of drugs.
Purchase a copy of this report at http://www.marketreportsonline.com/contacts/purchase.php?name=396023.
Product Coverage: Anti-Acne Drugs, Solodyn, Doryx, Epiduo, Absorica & Aczone
Regional Coverage: United States, Europe, Asia Pacific & Japan
Company Coverage: Foamix Pharmaceuticals HELLA, Valeant Pharmaceuticals, Dermira & Actavis Plc
Major points from Table of Contents (http://www.marketreportsonline.com/396023-toc.html) are listed below:
List of Figures
Figure 1: Acne Treatment Paradigm
Figure 2: Global Acne Market Size, (In US$ Billions), 2009-2013
Figure 3: Global Acne Market Size - Forecast (In US$ Billions), 2014-2019
Figure 4: Penetration of Total U.S. Minocycline Market v/s SOLODYN, 2012-2019
Figure 5: SOLODYN Worldwide Sales, (In US$ Millions), 2010-2011
Figure 6: DORYX Worldwide Sales, (In US$ Millions), 2010-2011
Figure 7: DORYX US Market Share (In percent), (Jan 2014- April 2014)
Figure 8: EPIDUO Worldwide Sales, (In US$ Millions), 2010-2011
Figure 9: Preferred Topical Therapy
Figure 10: ABSORICA Growing Market Penetration in the US, Nov-12-Nov-14
Figure 11: ACZONE Worldwide Sales (In US$ Millions), 2010-2011
Figure 12: Global Dermatology Market Size, (In US$ Billion), 2009-2014E
Figure 13: Segmentation of the U.S. Acne Market
Figure 14: US Oral Prescription Drugs Split for Acne Drugs – Reimbursement by Payor Type, 2013
Figure 15: US Branded Topical Prescription Drugs Split for Acne Drugs – Reimbursement by Payor Type, 2013
Figure 16: US Market Share of Oral Brands – Anti-Acne Market
Figure 17: US Market Share of Topical Brands – Anti-Acne Market
Figure 18: Acne Treatment with Self-medication in Europe's Main Markets
Figure 19: Anti-Acne Market in Asia Pacific (In US$ Millions), 2009-2013
Figure 20: Anti-Acne Market in Asia Pacific (In US$ Millions) – Forecast: 2014 -2019
Other Related Reports on Pharmaceuticals Market:
Global Biosimilar Market Trends & Opportunities: 2015 Edition (http://www.marketreportsonline.com/395635.html) This report analyzes the global biologics market, with exhaustive discussion on demand of Biosimilars with increase in patent expiry of innovator drugs. The key market challenges recognized by the analysts and the major trends biosimilar market are presented in the report.
US Pharmacy Benefit Management (PBM) Industry Report: 2014 Edition (http://www.marketreportsonline.com/395328.html) The PBM providers control drug spending and utilization by virtue of their advanced tools and techniques, encouraging use of generics and other lower-cost medications. In the US, there are some independent PBM’s while some are owned by managed care organizations and retail pharmacies.
The US Chronic Pain Market - Focus on Opioids: Trends & Opportunities (2014-2019) (http://www.marketreportsonline.com/376611.html) Chronic pain, defined as pain that lasts longer than six months and about 100 million Americans suffer from chronic pain that could be mild or agonizing, episodic or continuous, merely inconvenient or totally incapacitating.
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252.
Tel: + 1 888 391 5441